Asunto(s)
Dermatofibrosarcoma/patología , Neoplasias Cutáneas/patología , Pigmentación de la Piel , Biomarcadores de Tumor/análisis , Biopsia , Preescolar , Dermatofibrosarcoma/química , Dermatofibrosarcoma/cirugía , Humanos , Inmunohistoquímica , Masculino , Neoplasias Cutáneas/química , Neoplasias Cutáneas/cirugíaAsunto(s)
Centros Médicos Académicos , Agotamiento Profesional/epidemiología , Dermatólogos/psicología , Relajación/psicología , Tolerancia al Trabajo Programado/psicología , Adulto , Factores de Edad , Anciano , Estudios Transversales , Femenino , Humanos , Relaciones Interprofesionales , Masculino , Persona de Mediana Edad , Relaciones Médico-Paciente , Embarazo , Medición de Riesgo , Factores Sexuales , Estados UnidosRESUMEN
Lyme disease is the most common tick-borne disease in the United States and has a multitude of systemic effects. Infrequently, however, Lyme disease is seen to cause liver dysfunction. Dermatologists should be aware that early, disseminated borreliosis can present with multiple erythema migrans plaques and hepatitis.
Asunto(s)
Hepatitis/complicaciones , Enfermedad de Lyme/complicaciones , Adulto , Eritema Crónico Migrans/complicaciones , Humanos , Enfermedad de Lyme/diagnóstico , Enfermedad de Lyme/tratamiento farmacológico , Enfermedad de Lyme/patología , Masculino , Muslo/patologíaRESUMEN
Patients often are apprehensive about starting biologic medications for their psoriasis. Typical fears include anxiety regarding possible side effects and reluctance in accepting their proven efficacy. In this study, we aimed to evaluate patients' willingness to take a biologic medication for their psoriasis if presented with clinical trial evidence, an anecdote, or both. A prospective online survey study was performed in 222 patients with psoriasis. Patients were randomized to receive clinical trial evidence of a biologic medication's efficacy and safety, an anecdote of a single patient's positive experience, or both. Responses were recorded on a 10-point Likert scale and evaluated using the Kruskal-Wallis test followed by Dunn test. Results indicated that presenting an anecdote-alone or in combination with clinical trial evidence-may be an effective way to improve patients' willingness to take a biologic medication for psoriasis.